Quantum Leap: Norte programme de financement pour la recherche sur la découverte de médicaments (Quantum Leap: Pharma-led Funding Program for Drug Discovery Research)

By mmuise

CQDM’s Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Quantum Leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

Comments on Funding:


Deadline: February 15, 2024

The Quantum Leap pharma-led funding program for drug discovery research is open to all SMEs and public research institutions in Canada.

Application Steps:


Documentation Needed:


Other Things to Note:

1. Deadline to participate in the next selection round: November 16, 2023.
2. CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy.

About the author